Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02347631 · ClinicalTrials.gov registry record · NA

DAILIES TOTAL1 Versus ACUVUE TruEye - Effects on the Biology of the Ocular Surface and Lid Margin

A NA study of Myopia and Soft Contact Lenses, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
118
Enrollment target
1
Study location

NCT02347631 is a NA study of Myopia and Soft Contact Lenses that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 118 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02347631, a NA study of Myopia and Soft Contact Lenses, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, single center, randomized, bilateral crossover, dispensing clinical trial to evaluate the effects of the water gradient lens, DAILIES TOTAL1, on the biology of corneal epithelium over two months of daily wear compared to wear of a control high oxygen permeable silicone hydrogel daily disposable contact lens, the ACUVUE TruEye; and to correlate these changes with alterations in the lid wiper, tear film and cellular changes at the limbus. The total proposed duration of this study is 12 months to ensure enrollment of up to 94 established contact lens wearers, with anticipated completion of 84. Data will be collected at baseline and following 2 months of daily wear for each lens type. Based upon data from the investigators previous contact lens clinical trials, a 1 month washout period is required prior to initiating lens wear and also between lens wear periods for the two types of lenses in order to eliminate any potential residual solution or lens effects on the corneal epithelium and restore homeostasis. The study is scheduled to commence upon Institutional Review Board approval.

Interventions

  • DEVICE Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye
  • DEVICE Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1.

Study Locations (1)

Texas

  • Aston Ambulatory Care Center - Dallas

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2016-04
Est. Completion 2018-06
Phase NA

What the Registry Record Tells You About NCT02347631

The ClinicalTrials.gov registry entry for NCT02347631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (56% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye is the first listed.

NCT02347631 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02347631 about?

NCT02347631 is a clinical study titled "DAILIES TOTAL1 Versus ACUVUE TruEye - Effects on the Biology of the Ocular Surface and Lid Margin". This is a prospective, single center, randomized, bilateral crossover, dispensing clinical trial to evaluate the effects of the water gradient lens, DAILIES TOTAL1, on the biology of corneal epithelium over two months of daily wear compared to wear of a control high oxygen permeable silicone hydroge...

What is the current status of trial NCT02347631?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2016-04. Estimated completion is 2018-06.

What conditions does trial NCT02347631 study?

This clinical trial studies the following conditions: Myopia, Soft Contact Lenses.

What interventions are being tested in trial NCT02347631?

The interventions under investigation include: Soft Contact Lens - Daily Disposable Alcon Dailies Total 1 and ACUVUE TruEye (DEVICE), Soft Contact Lens - Acuvue TruEye and Alcon DAILIES TOTAL 1. (DEVICE).

Who is sponsoring clinical trial NCT02347631?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02347631 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.